Optimization of the Conditions of Analysis of Exhaled Air by Gas Chromatography–Mass Spectrometry for the Noninvasive Diagnostics of Lung Cancer


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We optimized procedures for the collection, preparation, and storage of samples of exhaled air and the conditions for determining volatile organic compounds in exhaled air by gas chromatography–mass spectrometry (GC–MS), the presence or change in the concentration of which can be caused by lung cancer. The analysis circuit includes group adsorption preconcentration followed by the thermal desorption and determination of analytes by GC–MS. Polymer bags of a Tedlar® film were used for sample collection. The conditions and periods of the storage of samples in bags and adsorption tubes are determined. A method for cleaning and conditioning bags is proposed. For preconcentrating exhaled air components, we used hydrophobic adsorbents (Porapak™ P, Porapak™ Q, and Tenax® TA) and three-section tubes containing Tenax® GR, Carbopack™ B, and Carbosieve® S-III. Their relative efficiency was evaluated by assessing the residual background of gas emission from the adsorbent, the magnitude of the analytical signal, the efficiency of adsorption/desorption, and the efficiency of storage. The conditions for the preconcentration of volatile organic compounds (volume and rate of aspiration, time, and temperature of thermal desorption) are optimized. The main volatile organic compounds in the exhaled air of conditionally healthy volunteers were identified, and their concentrations are evaluated.

Sobre autores

I. Gorbunov

Institute of Chemistry, St. Petersburg State University

Autor responsável pela correspondência
Email: i.s.gorbunov@spbu.ru
Rússia, St. Petersburg, 198504

A. Gubal’

Institute of Chemistry, St. Petersburg State University

Email: i.s.gorbunov@spbu.ru
Rússia, St. Petersburg, 198504

A. Ganeev

Institute of Chemistry, St. Petersburg State University; Institute of Toxicology, Federal Medical-Biological Agency

Email: i.s.gorbunov@spbu.ru
Rússia, St. Petersburg, 198504; St. Petersburg, 192019

O. Rodinkov

Institute of Chemistry, St. Petersburg State University

Email: i.s.gorbunov@spbu.ru
Rússia, St. Petersburg, 198504

L. Kartsova

Institute of Chemistry, St. Petersburg State University

Email: i.s.gorbunov@spbu.ru
Rússia, St. Petersburg, 198504

E. Bessonova

Institute of Chemistry, St. Petersburg State University

Email: i.s.gorbunov@spbu.ru
Rússia, St. Petersburg, 198504

A. Arsen’ev

Petrov National Oncology Medical Research Center, Ministry of Health of the Russian Federation

Email: i.s.gorbunov@spbu.ru
Rússia, St. Petersburg, 197758

A. Nefedov

Petrov National Oncology Medical Research Center, Ministry of Health of the Russian Federation

Email: i.s.gorbunov@spbu.ru
Rússia, St. Petersburg, 197758

L. Kraeva

Pasteur Research Institute of Epidemiology and Microbiology

Email: i.s.gorbunov@spbu.ru
Rússia, St. Petersburg, 197101


Declaração de direitos autorais © Pleiades Publishing, Inc., 2019

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies